ARNA
Price:
$99.99
Market Cap:
$0
Arena Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing innovative therapeutic agents, specifically designed with distinct pharmacological and pharmacokinetic profiles, for a global patient population. Its extensive pipeline features several key investigational medicines. Etrasimod (APD334) is undergoing diverse clinical evaluations, including a Phase III study for ulcerative colitis, a Phase IIb/III trial for Crohn's disease, a Phase II trial for alopecia areata, a separate Phase III trial for atopic dermatitis, and a Phase IIb study for eosinophilic esophagitis. Olorinab (APD371) is currently in a Phase IIb clinical trial, targeting abdominal discomfort linked to ir...[Read more]
Industry
Biotechnology
IPO Date
2000-07-28
Stock Exchange
NASDAQ
Ticker
ARNA
According to Arena Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -70.77%. This represents a change of 283.98% compared to the average of -18.43% of the last 4 quarters.
The mean historical ROE of Arena Pharmaceuticals, Inc. over the last ten years is -63.52%. The current -70.77% ROE has changed 11.42% with respect to the historical average. Over the past ten years (40 quarters), ARNA's ROE was at its highest in in the December 2016 quarter at 96.66%. The ROE was at its lowest in in the September 2016 quarter at -371.30%.
Average
-63.52%
Median
-50.28%
Minimum
-201.67%
Maximum
37.10%
Discovering the peaks and valleys of Arena Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 504.04%
Maximum Annual ROE = 37.10%
Minimum Annual Increase = -865.15%
Minimum Annual ROE = -201.67%
| Year | ROE | Change |
|---|---|---|
| 2021 | -92.18% | 146.08% |
| 2020 | -37.46% | -200.96% |
| 2019 | 37.10% | -865.15% |
| 2018 | -4.85% | -89.01% |
| 2017 | -44.13% | -21.80% |
| 2016 | -56.43% | -72.02% |
| 2015 | -201.67% | 57.80% |
| 2014 | -127.80% | 504.04% |
| 2013 | -21.16% | -75.58% |
| 2012 | -86.66% | -91.62% |
The current ROE of Arena Pharmaceuticals, Inc. (ARNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-30.85%
5-year avg
-28.30%
10-year avg
-63.52%
Arena Pharmaceuticals, Inc.’s ROE is greater than IVERIC bio, Inc. (-39.26%), less than Reata Pharmaceuticals, Inc. (47.21%), less than Abcam plc (0.76%), greater than Roivant Sciences Ltd. (-6.85%), greater than Mirati Therapeutics, Inc. (-61.91%), greater than Cerevel Therapeutics Holdings, Inc. (-72.44%), less than Opthea Limited (44.23%), greater than SpringWorks Therapeutics, Inc. (-35.72%), less than R1 RCM Inc. (0.12%), greater than MorphoSys AG (-183.80%),
| Company | ROE | Market cap |
|---|---|---|
| -39.26% | $5.51B | |
| 47.21% | $6.57B | |
| 0.76% | $5.52B | |
| -6.85% | $21.61B | |
| -61.91% | $4.12B | |
| -72.44% | $8.19B | |
| 44.23% | $4.24B | |
| -35.72% | $3.54B | |
| 0.12% | $6.04B | |
| -183.80% | $2.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arena Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arena Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Arena Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Arena Pharmaceuticals, Inc. (ARNA)?
What is the highest ROE for Arena Pharmaceuticals, Inc. (ARNA)?
What is the 3-year average ROE for Arena Pharmaceuticals, Inc. (ARNA)?
What is the 5-year average ROE for Arena Pharmaceuticals, Inc. (ARNA)?
How does the current ROE for Arena Pharmaceuticals, Inc. (ARNA) compare to its historical average?